Trial Profile
EFFICACY AND SAFETY OF ACITRETIN IN DOSES OF 25mg, 35mg or 50mg IN PATIENTS WITH SEVERE PLAQUE TYPE PSORIASIS: A RANDOMISED,DOUBLE BLIND , PARALLEL GROUP DOSE- RANGING STUDY.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Mar 2024
Price :
$35
*
At a glance
- Drugs Acitretin (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 07 Jan 2010 New trial record